阿摩線上測驗 登入

試題詳解

試卷:112年 - 112 消化系內科專科醫師甄審試題#131327 | 科目:消化系內科專科醫師

試卷資訊

試卷名稱:112年 - 112 消化系內科專科醫師甄審試題#131327

年份:112年

科目:消化系內科專科醫師

80. 關於 Cholangiocarconoma (CCA)的敘述,下列何者正確?
(1) Adjuvant chemotherapy with capecitabine for 6 months after surgical resection with curative intent is recommended for intrahepatic CCA, S-1 is
an alternative option
(2) Liver transplantation is a potentially curative option for intrahepatic and
perihilar CCA
(3) Entrectinib can be recommended as second- line treatment for NTRK gene
fusion-positive tumors
(4) Durvalumab plus Gemcitabine and Cisplatin significantly improved overall
survival (OS) versus Gemcitabine plus Cisplatin for advanced biliary tract cancer
(5) Cirrhosis is one of the risk factors of intrahepatic CCA
(A) (2)+(4)
(B) (1)+(2)+(3)+(4)
(C) (2)+(3)+(4)
(D) (1)+(2)+(3)+(4)+(5)

(E) (1)+(2)+(4)
正確答案:登入後查看

詳解 (共 1 筆)

推薦的詳解#6814650
未解鎖
1. 題目解析 本題考察有關膽管癌(C...
(共 1565 字,隱藏中)
前往觀看
0
0